Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,684,000 | -1,294,000 | -419,000 | -615,000 | -1,082,000 |
| Depreciation Amortization | 790,000 | 531,000 | 272,000 | 1,153,000 | 887,000 |
| Income taxes - deferred | -666,000 | -613,000 | -189,000 | -317,000 | -349,000 |
| Accounts receivable | N/A | N/A | N/A | 12,000 | N/A |
| Other Working Capital | -190,000 | -507,000 | -497,000 | -72,000 | -364,000 |
| Other Operating Activity | 2,422,000 | 1,862,000 | 709,000 | 1,207,000 | 1,092,000 |
| Operating Cash Flow | $672,000 | $-21,000 | $-124,000 | $1,368,000 | $184,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -330,000 | -220,000 | -124,000 | -458,000 | -339,000 |
| Net Acquisitions | -15,000 | -15,000 | -15,000 | N/A | N/A |
| Purchase Of Investment | -56,000 | -55,000 | -12,000 | -46,000 | -44,000 |
| Sale Of Investment | 40,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 951,000 | 612,000 | 295,000 | 1,472,000 | 1,050,000 |
| Investing Cash Flow | $590,000 | $322,000 | $144,000 | $968,000 | $667,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 700,000 | 700,000 |
| Debt Issued | N/A | N/A | N/A | 2,451,000 | 2,451,000 |
| Debt Repayment | -956,000 | -956,000 | N/A | -4,152,000 | -4,152,000 |
| Dividend Paid | -78,000 | -78,000 | -78,000 | N/A | N/A |
| Other Financing Activity | -83,000 | -83,000 | -73,000 | -912,000 | -336,000 |
| Financing Cash Flow | $-1,117,000 | $-1,117,000 | $-151,000 | $-1,913,000 | $-1,337,000 |
| Exchange Rate Effect | -53,000 | -153,000 | -104,000 | -30,000 | -98,000 |
| Beginning Cash Position | 3,227,000 | 3,227,000 | 3,227,000 | 2,834,000 | 2,834,000 |
| End Cash Position | 3,319,000 | 2,258,000 | 2,991,000 | 3,227,000 | 2,250,000 |
| Net Cash Flow | $92,000 | $-969,000 | $-236,000 | $393,000 | $-584,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 672,000 | -21,000 | -124,000 | 1,368,000 | 184,000 |
| Capital Expenditure | -369,000 | -221,000 | -124,000 | -526,000 | -407,000 |
| Free Cash Flow | 303,000 | -242,000 | -248,000 | 842,000 | -223,000 |